Top COVID-19 Research: Timely, Curated and Vetted by Experts

From the Curator-in-Chief's Desk—Oct. 21, 2022

Lynn Enquist
Lynn Enquist, Ph.D., Curator-in-Chief
Dear Colleagues,

Thank you for engaging with the articles, postings and virtual journals club events on ASM’s COVID-19 Research Registry (Registry). We hope the Registry has been a valuable resource for you throughout the pandemic. As we envisioned and created the Registry, it was our aim to bring together a curated collection of research that is timely, impactful and vetted by experts. It is our hope that we’ve fulfilled that mission and provided you with the most significant COVID-19 research over the past 2.5 years.

Since the Registry launched in April 2020, more than 2,500 articles have been published on it and more than 80,000 users have viewed its content, with over 130,000 pages viewed. Throughout the lifespan of the Registry, we have published weekly COVID-19 research updates by the Curator-in-Chief and more than 50 biweekly commentaries by the curators. We are also proud to have hosted 16 monthly virtual journal clubs, which attracted a global audience of researchers and educators from more than 40 countries. These numbers are a testament to the success and impact of the COVID-19 Research Registry.

As COVID-19 transitions from a pandemic to an endemic phase, we have completed our original intention to establish the COVID-19 Registry to provide reliable and up-to-date information about COVID-19 research. The web traffic to the Registry has decreased starting this summer, and engagement on has shifted to other topics. Therefore, we will pause the activities of the COVID-19 Registry by the end of Oct. 2022. Although no new update will be added, the Registry site and all the information will remain open for the community to access. ASM will continue to monitor the COVID-19 situation and will share and publish the most important information on and in ASM’s journals.

The COVID-19 Research Registry has been an exciting collaboration between ASM volunteer leaders, staff and members, and we are grateful for the opportunity to rise to the moment and meet the need for timely, vetted information about COVID-19. Thank you, again, for engaging with this project. It is readers and participants like you who have made ASM’s COVID-19 Research Registry a success.

Stefano Bertuzzi, Ph.D., MPH                               Lynn Enquist, Ph.D.
ASM CEO                                                              COVID-19 Research Registry Curator-in-Chief


How is the genome of SARS-CoV-2 evolving? What mechanism does the coronavirus use to target human cells? How does the immune system react to SARS-CoV-2?



Will serology provide the ultimate answer? Does the existence of the antibody equal protection due to antibody neutralization? How often should patients be tested?


What are the results of the newest treatment? What drugs are in the pipeline? What are the latest outcomes from clinical trials?



What are the different kinds of vaccines? Do coronaviruses evolve to escape vaccines? What have we learned from work with Ebola virus and SARS vaccines development?


How does a pandemic start? How long will this pandemic last: can data models give us some hints? COVID-19 affects people differently depending on their age, how does this affect transmission? How does social distancing influence transmission rates?



Scientifically speaking, what is a coronavirus? What are the similarities and differences in structure and activities of SARS, MERS and SARS-CoV-2? What is the PK/PD of Remdesivir?

Educational Resources